Tremfya 200 mg/2 ml, Injektionslösung in einer Fertigspritze

7680665830025 CH-66583 Injektionslösung
Tremfya 200 mg/2 ml, Injektionslösung in einer Fertigspritze
google

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
06/08/2025
Summary of Product Characteristics
Français
06/08/2025
Summary of Product Characteristics
Italien
06/08/2025
Patient information leaflet
Allemand
14/06/2025
Patient information leaflet
Français
14/06/2025
Patient information leaflet
Italien
14/06/2025

Detailed composition

Substance Quantity Type Category
(N/A)
200.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 2090.20
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/11/2025

Authorization holder

Janssen-Cilag AG

6300 Zug

Authorization information

Swissmedic authorization number
66583
Drug name
Tremfya, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AC16
Authorization status
Z
Dispensing category
B
First authorization
13/06/2018
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Plaque Psoriasis, Psoriasis-Arthritis, Morbus Crohn, Colitis ulcerosa

Package details

Description (FR)
TREMFYA 200 mg/2 ml sol inj 200 mg 1 pce
Description (DE)
TREMFYA 200 mg/2 ml Inj Lös 200 mg 1 Stk
Market launch
28/07/2025
Narcotic (BTM)
No

Other package sizes (2)

TREMFYA sol inj 100 mg/ml ser pré 1 ml
1 FESP
GTIN: 7680665830018
View
TREMFYA 200 mg/2 ml sol inj 200 mg 2 pce
2 FESP
GTIN: 7680665830032
Not in V1